New combo therapy shows promise for follicular lymphoma patients
NCT ID NCT04246086
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tests a combination of two drugs, mosunetuzumab and lenalidomide, in people with follicular lymphoma, a type of blood cancer. The goal is to see if the combo is safe and works better than standard treatments. About 237 adults whose cancer has returned or needs treatment will take part. The study also compares giving one drug as a shot under the skin versus through an IV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Rennes - Hopital Pontchaillou
Rennes, 35033, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195-0001, United States
-
Duke University Medical Center
Durham, North Carolina, 27710-4000, United States
-
Fairview Hospital
Cleveland, Ohio, 44111, United States
-
Freeman Hospital
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Fudan University Shanghai Cancer Center
Shanghai, 200120, China
-
Hillcrest Hospital
Mayfield Heights, Ohio, 44124, United States
-
Hospital Universitario Fundacion Jimenez Diaz.
Madrid, 28040, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
-
Mary Bird Perkins Cancer Ctr
Baton Rouge, Louisiana, 70809, United States
-
Norton Cancer Institute - St. Matthews
Louisville, Kentucky, 40207-4723, United States
-
Nottingham University Hospitals NHS Trust - City Hospital
Nottingham, NG5 1PB, United Kingdom
-
Rhode Island Hematology/Oncology Program
Woonsocket, Rhode Island, 02895-4720, United States
-
Swedish Medical Center
Seattle, Washington, 98122, United States
-
Tennessee Oncology PLLC - Franklin
Franklin, Tennessee, 37067, United States
-
Tennessee Oncology;Chattanooga Oncology & Hematology Associates
Chattanooga, Tennessee, 37404, United States
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
The First Affiliated Hospital of Xiamen University
Xiamen, 361003, China
-
The First Hospital of Jilin University
Changchun, 130021, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjing, 300060, China
-
University College London Hospitals NHS Foundation Trust - University College Hospital
London, NW1 2PG, United Kingdom
-
University of Miami Miller School of Medicine
Miami, Florida, 33136-1002, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
West China Hospital, Sichuan University
Chengdu, 610041, China
Conditions
Explore the condition pages connected to this study.